Skip to content

BPC-157 vs VIP

Updated 9 sources

Key differences

  1. 1VIP targets inflammation, airways and circulation. BPC-157 is framed as soft-tissue repair and is mostly preclinical.

Side by side

Facts from each record, in the same words as their own pages.
BPC-157 and VIP side by side
BPC-157VIP
Category
  • Healing & recovery
  • Immune, Other
Evidence
  • Limited human data
  • Limited human data
FDA status
  • Not FDA approvedRegulatory
  • FDA 503A Category 1Regulatory
WADA
  • Prohibited
  • Not confirmed
Half-life
  • Under 30 minutes for the intact peptide in rats and dogs. No human data. The 4-hour figure on many sites has no primary source.Competitor guide
  • About 1 minute in the blood after IV infusion in healthy volunteers. Enzymes such as NEP and DPP-IV break it down fast.Clinical study
Routes
  • Subcutaneous injection, Oral
  • Nasal, Subcutaneous injection, Other route
Forms
  • Vial (powder), Capsule, Tablet
  • Nasal spray, Vial (powder), Other form
Reported doses
  • 100 to 750 mcg (subcutaneous injection)
  • 1.6 to 10 mcg/kg (subcutaneous injection)
  • 250 to 1,000 mcg (oral)
  • 50 to 200 mcg (nasal)
  • 50 to 500 mcg (subcutaneous injection)
  • 25 to 100 mcg (other route)
Most cited frequency
  • Once daily
  • Once or twice daily
Vial sizes
  • 5 mg, 10 mg, 20 mg, 30 mg, 40 mgCompetitor guide
  • 10 mg, 5 mgCompetitor guide
Mixed vial keeps
  • Fridge at 2 to 8 C, dark, never frozen.Competitor guide
  • Fridge at 2 to 8 C, not frozen.Competitor guide
Protocols on file
  • 23
  • 15

Doses shown are what sources report, labelled by origin. Not medical advice.

Read each in full

Sources

9 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.

Competitor guide2

  1. VIP peptide dosing guidepeptidedosingprotocols.com · checked Oct 24, 2026
  2. BPC-157peptidesinsider.com · checked Oct 23, 2026